| Dino James Delaportas, MD | |
|
11 Point Of Vw, Bridgeport, WV 26330 | |
| (304) 641-1822 | |
| (304) 250-9933 |
| Full Name | Dino James Delaportas |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 47 Years |
| Location | 11 Point Of Vw, Bridgeport, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639124159 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 22140 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mon Health Medical Center | Morgantown, WV | Hospital |
| United Hospital Center | Bridgeport, WV | Hospital |
| West Virginia University Hospitals | Morgantown, WV | Hospital |
| Preston Memorial Hospital | Kingwood, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monongalia County General Hospital Company | 9638073380 | 182 |
| Mountainstate Infectious Disease Pllc | 5991044653 | 2 |
News Archive
Swedish researchers looked at the risk of having health conditions including high blood pressure, asthma, diabetes, heart disease or epilepsy among adults who had been born prematurely. The study titled, "Prevalence of Survival Without Major Comorbidities Among Adults Born Prematurely," was published in the latest issue of the JAMA this month.
As part of its ongoing "Federal Player of the Week" series with the Partnership for Public Service, the Washington Post examines the role of Richard Greene, the head of USAID's Office of Health, Infectious Diseases, and Nutrition in the Bureau of Global Health.
Leading public health researchers have called for the sale of tobacco to be phased out by 2040, showing that with sufficient political support and stronger evidence-based action against the tobacco industry, a tobacco-free world – where less than 5% of adults use tobacco – could be possible in less than three decades.
Complex neurotechnological devices are required to directly select and influence brain waves inside the skull's interior. Although it has become relatively easy to implement the devices, researchers are still faced with challenges when trying to keep them running properly in living organisms over time.
Neurologix, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for intellectual property central to the company's approach to the treatment of epilepsy. The patent allowance specifically refers to Neurologix's patent application, "Methods and Compositions for the Treatment of Neurological Disease," which covers the treatment of seizures associated with temporal lobe epilepsy by direct administration into the brain's temporal lobe of an AAV vector encoding Neuropeptide Y (NPY).
› Verified 6 days ago
| Entity Name | Monongalia County General Hospital Company |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447673223 PECOS PAC ID: 9638073380 Enrollment ID: O20031124000459 |
News Archive
Swedish researchers looked at the risk of having health conditions including high blood pressure, asthma, diabetes, heart disease or epilepsy among adults who had been born prematurely. The study titled, "Prevalence of Survival Without Major Comorbidities Among Adults Born Prematurely," was published in the latest issue of the JAMA this month.
As part of its ongoing "Federal Player of the Week" series with the Partnership for Public Service, the Washington Post examines the role of Richard Greene, the head of USAID's Office of Health, Infectious Diseases, and Nutrition in the Bureau of Global Health.
Leading public health researchers have called for the sale of tobacco to be phased out by 2040, showing that with sufficient political support and stronger evidence-based action against the tobacco industry, a tobacco-free world – where less than 5% of adults use tobacco – could be possible in less than three decades.
Complex neurotechnological devices are required to directly select and influence brain waves inside the skull's interior. Although it has become relatively easy to implement the devices, researchers are still faced with challenges when trying to keep them running properly in living organisms over time.
Neurologix, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for intellectual property central to the company's approach to the treatment of epilepsy. The patent allowance specifically refers to Neurologix's patent application, "Methods and Compositions for the Treatment of Neurological Disease," which covers the treatment of seizures associated with temporal lobe epilepsy by direct administration into the brain's temporal lobe of an AAV vector encoding Neuropeptide Y (NPY).
› Verified 6 days ago
| Entity Name | Mountainstate Infectious Disease Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114491792 PECOS PAC ID: 5991044653 Enrollment ID: O20190225003019 |
News Archive
Swedish researchers looked at the risk of having health conditions including high blood pressure, asthma, diabetes, heart disease or epilepsy among adults who had been born prematurely. The study titled, "Prevalence of Survival Without Major Comorbidities Among Adults Born Prematurely," was published in the latest issue of the JAMA this month.
As part of its ongoing "Federal Player of the Week" series with the Partnership for Public Service, the Washington Post examines the role of Richard Greene, the head of USAID's Office of Health, Infectious Diseases, and Nutrition in the Bureau of Global Health.
Leading public health researchers have called for the sale of tobacco to be phased out by 2040, showing that with sufficient political support and stronger evidence-based action against the tobacco industry, a tobacco-free world – where less than 5% of adults use tobacco – could be possible in less than three decades.
Complex neurotechnological devices are required to directly select and influence brain waves inside the skull's interior. Although it has become relatively easy to implement the devices, researchers are still faced with challenges when trying to keep them running properly in living organisms over time.
Neurologix, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for intellectual property central to the company's approach to the treatment of epilepsy. The patent allowance specifically refers to Neurologix's patent application, "Methods and Compositions for the Treatment of Neurological Disease," which covers the treatment of seizures associated with temporal lobe epilepsy by direct administration into the brain's temporal lobe of an AAV vector encoding Neuropeptide Y (NPY).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dino James Delaportas, MD 11 Point Of Vw, Bridgeport, WV 26330-1082 Ph: (304) 641-1822 | Dino James Delaportas, MD 11 Point Of Vw, Bridgeport, WV 26330 Ph: (304) 641-1822 |
News Archive
Swedish researchers looked at the risk of having health conditions including high blood pressure, asthma, diabetes, heart disease or epilepsy among adults who had been born prematurely. The study titled, "Prevalence of Survival Without Major Comorbidities Among Adults Born Prematurely," was published in the latest issue of the JAMA this month.
As part of its ongoing "Federal Player of the Week" series with the Partnership for Public Service, the Washington Post examines the role of Richard Greene, the head of USAID's Office of Health, Infectious Diseases, and Nutrition in the Bureau of Global Health.
Leading public health researchers have called for the sale of tobacco to be phased out by 2040, showing that with sufficient political support and stronger evidence-based action against the tobacco industry, a tobacco-free world – where less than 5% of adults use tobacco – could be possible in less than three decades.
Complex neurotechnological devices are required to directly select and influence brain waves inside the skull's interior. Although it has become relatively easy to implement the devices, researchers are still faced with challenges when trying to keep them running properly in living organisms over time.
Neurologix, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for intellectual property central to the company's approach to the treatment of epilepsy. The patent allowance specifically refers to Neurologix's patent application, "Methods and Compositions for the Treatment of Neurological Disease," which covers the treatment of seizures associated with temporal lobe epilepsy by direct administration into the brain's temporal lobe of an AAV vector encoding Neuropeptide Y (NPY).
› Verified 6 days ago
Dr. Michael T. Angotti, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 527 Medical Park Dr, Suite 307, Bridgeport, WV 26330 Phone: 304-933-3332 Fax: 304-933-3318 | |
Brandon Shiflett, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 681-342-1000 | |
Nabeel Ghabra, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 527 Medical Park Dr Ste 402, Bridgeport, WV 26330 Phone: 681-342-3690 Fax: 681-342-3695 | |
Salma Khatoon, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 681-342-1852 | |
Dr. Nathaniel James Kesner, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 304-623-1330 | |
Dr. Susan W. Miller, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 140 W Main St, Bridgeport, WV 26330 Phone: 304-842-2206 Fax: 304-842-2580 | |
Mrs. Kimberly J Fairley, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 527 Medical Park Dr Ste 402, Bridgeport, WV 26330 Phone: 681-342-3690 |